首页 › 基金 › NEA Management Company, LLC › KPTI

NEA Management Company, LLC 对 KPTI 的持仓历史

KARYOPHARM THERAPEUTICS INC · 医疗保健

NEA Management Company, LLC 在 Q2 2026 的 13F 申报中披露持有 KPTI(KARYOPHARM THERAPEUTICS INC)576,780 股,市值约 US$5.6M,约占其申报组合的 0.35%,在其申报持仓中市值排名第 19 位。 NEA Management Company, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)576.78K 股
申报持仓市值$5.64M
组合权重0.35%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

NEA Management Company, LLC 对 KPTI 的持仓演变

NEA Management Company, LLC 于 Q2 2026 首次披露 KPTI 持仓:576,780 股(约 US$5.6M)。

逐季持仓明细

季度股数金额变化
Q2 2026 576.78K $5.64M 新进

关于 KPTI 与 13F 数据

KPTI(KARYOPHARM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 KPTI,申报仓位最大的包括:ACORN CAPITAL ADVISORS, LLC (US$14.8M), Catalio Capital Management, LP (US$9.2M), Avidity Partners Management LP (US$9.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 KPTI 的基金

查看 KPTI 的全部基金持有人 →

常见问题

How long has NEA Management Company, LLC held KPTI?

NEA Management Company, LLC has disclosed KPTI holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is NEA Management Company, LLC's current position in KPTI?

As of Q2 2026, NEA Management Company, LLC holds 576.78K shares of KPTI (KARYOPHARM THERAPEUTICS INC), valued at $5.64M, representing 0.35% of its reported portfolio and ranking #19.

Has NEA Management Company, LLC been buying or selling KPTI?

In the latest 13F filing (Q2 2026), NEA Management Company, LLC newly opened its position in KPTI.

Which other funds hold KPTI?

Other major institutional holders of KPTI include ACORN CAPITAL ADVISORS, LLC, Catalio Capital Management, LP, Avidity Partners Management LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.